Search
Akari Therapeutics PLC
AKTXAdd to Watchlist
8.625USD
+0.235+2.80%
Close 10-07 16:00（ET）
16.79MMarket Cap
LossP/E TTM
TradingKey Chart
Intraday
1m
30m
1h
D
W
M
D
Today
+2.80%
5 Days
-7.26%
1 Month
-24.80%
6 Months
+126.97%
Year to Date
-25.39%
1 Year
-79.46%
Key Figures
8.460Open
8.625High
1.57KVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
0.08%Turnover Ratio
8.390Prev. Close
8.050Low
13.39KTurnover
LossP/E Static
1.15P/B
0.00%Div Yield TTM
-66.11%ROA
29.32052wk High
0.07Volume Ratio
-19.79MNet Profit
1.95MShares
-15.4400EPS TTM
1.47Beta
-155.28%ROE
4.80052wk Low
9.89%Amplitude
--Gross Margin
16.79MMarket Cap
-2.67Reward/Risk
263.49%Risk Rate
Analyst Rating
Akari Therapeutics PLC Technical Analysis
Technical Indicators
Sell
Summary
Sell
Moving Average
Strong sell
Financial Indicators
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
Earnings
Next reporting date
--
Reporting Period
2026Q2
Earnings / Forecast
-2.40/-1.28
Revenue / Forecast
--/0.00
Akari Therapeutics PLC Profile
SectorPharmaceuticals
Ticker SymbolAKTX
Number of employees8
CountryUnited States of America
Ownership
| Shareholders | Proportion |
|---|---|
| Huh (Hoyoung) | 10.26% |
| Patel (Samir Rashmikant) | 6.93% |
| Prudo-Chlebosz (Raymond) | 6.56% |
| Armistice Capital LLC | 5.95% |
| Shareholder Types | Proportion |
|---|---|
| Individual Investor | 24.55% |
| Hedge Fund | 6.27% |
| Investment Advisor/Hedge Fund | 1.80% |
| Family Office | 0.65% |
Related Instruments
+2.70%
+1.44%
+1.75%
+0.60%
+1.77%
+0.95%
+2.60%
+1.82%
+1.95%
+1.82%
+0.66%
+0.18%
-1.23%
+1.62%
+0.90%
+4.81%
+0.46%
+1.49%
-0.22%
-0.55%Popular Instruments
50837.500
-308.900 (-0.60%)
30982.400
-176.200 (-0.56%)
7772.800
-24.700 (-0.32%)
13715.000
-87.000 (-0.63%)
68680.000
-932.000 (-1.34%)
6098.000
-85.300 (-1.38%)
90.414
+2.504 (+2.85%)
336.670
+3.040 (+0.91%)
237.470
-1.770 (-0.74%)
4124.020
+13.630 (+0.33%)
FAQs
What is the current price of Akari Therapeutics PLC (AKTX)?
The current price of Akari Therapeutics PLC (AKTX) is 8.62.
What is the symbol of Akari Therapeutics PLC?
The ticker symbol of Akari Therapeutics PLC is AKTX.
What is the 52-week high of Akari Therapeutics PLC?
The 52-week high of Akari Therapeutics PLC is 29.32.
What is the 52-week low of Akari Therapeutics PLC?
The 52-week low of Akari Therapeutics PLC is 4.80.
What is the market capitalization of Akari Therapeutics PLC?
The market capitalization of Akari Therapeutics PLC is 16.79M.
Is Akari Therapeutics PLC (AKTX) currently rated as Buy, Hold, or Sell?
According to analysts, Akari Therapeutics PLC (AKTX) has an overall rating of Buy, with a price target of 29.12.
What is the Earnings Per Share (EPS TTM) of Akari Therapeutics PLC (AKTX)?
The Earnings Per Share (EPS TTM) of Akari Therapeutics PLC (AKTX) is -15.44.